 Carcinoma, Ductal, Breast
"Carcinoma, Ductal, Breast" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
| Descriptor ID |
D018270
|
| MeSH Number(s) |
C04.557.470.200.025.232.500 C04.557.470.615.132.500 C04.588.180.390 C17.800.090.500.390
|
| Concept/Terms |
Carcinoma, Ductal, Breast- Carcinoma, Ductal, Breast
- Carcinoma, Invasive Ductal, Breast
- Invasive Ductal Carcinoma, Breast
- Carcinoma, Infiltrating Duct
- Carcinomas, Infiltrating Duct
Carcinoma, Mammary Ductal- Carcinoma, Mammary Ductal
- Carcinomas, Mammary Ductal
- Mammary Ductal Carcinomas
- Mammary Ductal Carcinoma
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Ductal, Breast".
- Diseases [C]
- Neoplasms [C04]
- Neoplasms by Histologic Type [C04.557]
- Neoplasms, Glandular and Epithelial [C04.557.470]
- Carcinoma [C04.557.470.200]
- Adenocarcinoma [C04.557.470.200.025]
- Carcinoma, Ductal [C04.557.470.200.025.232]
- Carcinoma, Ductal, Breast [C04.557.470.200.025.232.500]
- Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
- Carcinoma, Ductal [C04.557.470.615.132]
- Carcinoma, Ductal, Breast [C04.557.470.615.132.500]
- Neoplasms by Site [C04.588]
- Breast Neoplasms [C04.588.180]
- Carcinoma, Ductal, Breast [C04.588.180.390]
- Skin and Connective Tissue Diseases [C17]
- Skin Diseases [C17.800]
- Breast Diseases [C17.800.090]
- Breast Neoplasms [C17.800.090.500]
- Carcinoma, Ductal, Breast [C17.800.090.500.390]
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Ductal, Breast".
This graph shows the total number of publications written about "Carcinoma, Ductal, Breast" by people in UAMS Profiles by year, and whether "Carcinoma, Ductal, Breast" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 1 | 0 | 1 | | 2022 | 3 | 0 | 3 | | 2021 | 1 | 0 | 1 | | 2020 | 2 | 0 | 2 | | 2019 | 2 | 1 | 3 | | 2018 | 3 | 1 | 4 | | 2016 | 5 | 2 | 7 | | 2015 | 4 | 1 | 5 | | 2014 | 1 | 1 | 2 | | 2013 | 4 | 0 | 4 | | 2012 | 2 | 1 | 3 | | 2011 | 3 | 1 | 4 | | 2010 | 3 | 2 | 5 | | 2009 | 1 | 0 | 1 | | 2007 | 2 | 1 | 3 | | 2006 | 3 | 0 | 3 | | 2004 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2002 | 0 | 1 | 1 | | 2000 | 1 | 0 | 1 | | 1998 | 3 | 0 | 3 | | 1996 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Carcinoma, Ductal, Breast" by people in Profiles over the past ten years.
-
Yan Z, Ngeow J, Allen J, Lim GH. Clinical presentations and outcomes of young women aged <40 yrs with Ductal carcinoma in situ. Breast Dis. 2023; 42(1):299-303.
-
Strand SH, Rivero-Guti?rrez B, Houlahan KE, Seoane JA, King LM, Risom T, Simpson LA, Vennam S, Khan A, Cisneros L, Hardman T, Harmon B, Couch F, Gallagher K, Kilgore M, Wei S, DeMichele A, King T, McAuliffe PF, Nangia J, Lee J, Tseng J, Storniolo AM, Thompson AM, Gupta GP, Burns R, Veis DJ, DeSchryver K, Zhu C, Matusiak M, Wang J, Zhu SX, Tappenden J, Ding DY, Zhang D, Luo J, Jiang S, Varma S, Anderson L, Straub C, Srivastava S, Curtis C, Tibshirani R, Angelo RM, Hall A, Owzar K, Polyak K, Maley C, Marks JR, Colditz GA, Hwang ES, West RB. Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts. Cancer Cell. 2022 12 12; 40(12):1521-1536.e7.
-
Weiser R, Polychronopoulou E, Klimberg VS. Reply to "The use of national datasets to evaluate outcomes for invasive lobular carcinoma". Cancer. 2022 09 15; 128(18):3418-3419.
-
Weiser R, Polychronopoulou E, Hatch SS, Haque W, Ghani HA, He J, Kuo YF, Gradishar WJ, Klimberg VS. Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis. Cancer. 2022 05 01; 128(9):1738-1747.
-
Almalki HS, Lim A, Allen JC, Teo SY, Lim GH. Usefulness of supplementary ultrasound surveillance in the detection of a second breast cancer in patients with ductal carcinoma in situ. Clin Breast Cancer. 2021 12; 21(6):521-525.
-
Louie RJ, Gaber CE, Strassle PD, Gallagher KK, Downs-Canner SM, Ollila DW. Trends in Surgical Axillary Management in Early Stage Breast Cancer in Elderly Women: Continued Over-Treatment. Ann Surg Oncol. 2020 Sep; 27(9):3426-3433.
-
Urbaniak A, Jousheghany F, Pi?a-Oviedo S, Yuan Y, Majcher-Uchanska U, Klejborowska G, Moorjani A, Monzavi-Karbassi B, Huczynski A, Chambers TC. Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells-in vitro and ex vivo study. J Biochem Mol Toxicol. 2020 Jun; 34(6):e22487.
-
Downs-Canner SM, Gaber CE, Louie RJ, Strassle PD, Gallagher KK, Muss HB, Ollila DW. Nodal positivity decreases with age in women with early-stage, hormone receptor-positive breast cancer. Cancer. 2020 03 15; 126(6):1193-1201.
-
Polamraju P, Haque W, Cao K, Verma V, Schwartz M, Klimberg VS, Hatch S, Niravath P, Butler EB, Teh BS. Comparison of outcomes between metaplastic and triple-negative breast cancer patients. Breast. 2020 Feb; 49:8-16.
-
Ekenga CC, Wang X, P?rez M, Schootman M, Jeffe DB. A Prospective Study of Weight Gain in Women Diagnosed with Early-Stage Invasive Breast Cancer, Ductal Carcinoma In Situ, and Women Without Breast Cancer. J Womens Health (Larchmt). 2020 04; 29(4):524-533.
-
Nayyar A, Strassle PD, Shen MR, Black JA, Gallagher KK, McGuire KP. Survival analysis of early-stage breast cancer patients undergoing axillary lymph node dissection and sentinel lymph node dissection. Am J Surg. 2018 10; 216(4):706-712.
-
Haque W, Verma V, Hatch S, Klimberg VS, Butler EB, Teh BS. Omission of chemotherapy for low-grade, luminal A N1 breast cancer: Patterns of care and clinical outcomes. Breast. 2018 Oct; 41:67-73.
-
Lim GH, Upadhyaya VS, Acosta HA, Lim JMA, Allen JC, Leong LCH. Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result. Eur J Surg Oncol. 2018 07; 44(7):945-950.
-
Zeidan YH, Habib JG, Ameye L, Paesmans M, de Azambuja E, Gelber RD, Campbell I, Nordenskj?ld B, Guti?rez J, Anderson M, Lluch A, Gnant M, Goldhirsch A, Di Leo A, Joseph DJ, Crown J, Piccart-Gebhart M, Francis PA. Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial. Int J Radiat Oncol Biol Phys. 2018 06 01; 101(2):316-324.
-
Klimberg VS. Data on Ductal Carcinoma In Situ Encumbered by Opinion. Oncology (Williston Park). 2016 09 15; 30(9):832-3.
-
Mateo AM, Pezzi TA, Sundermeyer M, Kelley CA, Klimberg VS, Pezzi CM. Atypical medullary carcinoma of the breast has similar prognostic factors and survival to typical medullary breast carcinoma: 3,976 cases from the National Cancer Data Base. J Surg Oncol. 2016 Oct; 114(5):533-536.
-
Makhoul I, Griffin RJ, Siegel E, Lee J, Dhakal I, Raj V, Jamshidi-Parsian A, Klimberg S, Hutchins LF, Kadlubar S. High-circulating Tie2 Is Associated With Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer. Am J Clin Oncol. 2016 06; 39(3):248-54.
-
Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, Wu W, Calin GA, Krishnamurthy S, Zhang XH, Buchholz TA, Ueno NT, Reuben JM, Woodward WA. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. J Natl Cancer Inst. 2016 08; 108(8).
-
Jacob JD, Hodge C, Franko J, Pezzi CM, Goldman CD, Klimberg VS. Rare breast cancer: 246 invasive secretory carcinomas from the National Cancer Data Base. J Surg Oncol. 2016 Jun; 113(7):721-5.
-
Gaitan-Gaona F, Said MC, Valdes-Rodriguez R. Cutaneous metastatic pigmented breast carcinoma. Dermatol Online J. 2016 Mar 16; 22(3).
-
Rivere AE, Chiasson KF, Corsetti RL, Fuhrman GM. An Assessment of Margins after Lumpectomy in Breast Cancer Management. Am Surg. 2016 Feb; 82(2):156-60.
-
Jeffe DB, P?rez M, Cole EF, Liu Y, Schootman M. The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up. Ann Surg Oncol. 2016 Mar; 23(3):735-43.
-
Erdem H, Gundogdu B, Ankarali H, Yasar M, Sener E, Oktay M, Bahadir A, Uzunlar AK, Gursan N, Ozaydin I, Sahiner C. Correlation of astrocyte elevated gene-1, basic-fibroblast growth factor, beta-catenin, Ki-67, tumor necrosis factor-alfa with prognostic parameters in ductal carcinomas and ductal intraepithelial neoplasms. Niger J Clin Pract. 2015 Sep-Oct; 18(5):638-43.
-
He Y, Zhang F, Flaherty P. RVD2: an ultra-sensitive variant detection model for low-depth heterogeneous next-generation sequencing data. Bioinformatics. 2015 Sep 01; 31(17):2785-93.
-
Makhoul I, Klimberg VS, Korourian S, Henry-Tillman RS, Siegel ER, Westbrook KC, Hutchins LF. Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer. Am J Clin Oncol. 2015 Feb; 38(1):74-9.
-
Stewart RL, Dell CM, Samayoa L. Myeloid sarcoma of the breast misdiagnosed as poorly differentiated mammary carcinoma with lobular features. Breast J. 2015 Mar-Apr; 21(2):192-3.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|